Change Country
Welcome to Luxembourg
Please read the important information below before continuing to our website

The Lyxor ETFs on this website may be restricted for certain individuals or in certain countries pursuant to the national regulations applicable to those individuals or countries. It is therefore your responsibility to ensure that you are authorised to invest in the Lyxor ETFs on this website. 

 

If you are an investor in the United Kingdom, please go to www.lyxoretf.co.uk  

If you are an investor in the Netherlands, please go to www.lyxoretf.nl  

If you are an investor in Italy, please go to www.lyxoretf.it  

If you are an investor in Spain, please go to www.lyxoretf.es  

If you are an investor in Austria, please go to www.lyxoretf.at  

If you are an investor in Germany, please go to www.lyxoretf.de   

If you are an investor in Singapore, please go to www.lyxoretf.com.sg  

If you are an investor in Switzerland, please go to www.lyxoretf.ch  

If you are an investor in Belgium, please go to www.lyxoretf.be  

If you are an investor in Poland, please go to www.lyxoretf.pl 

If you are an investor in Norway, please go to www.lyxoretf.no

If you are an investor in Denmark, please go to www.lyxoretf.dk

If you are an investor in Luxembourg, please go to www.lyxoretf.lu

If you are an investor in Sweden, please go to www.lyxoretf.se

If you are an investor in Finland, please go to www.lyxoretf.fi

 

 

The Lyxor ETFs on this website are undertakings for collective investment in transferable securities (UCITS) (i) domiciled in France and approved by the Autorité des Marchés Financiers (AMF) or, (ii) domiciled in Luxembourg, approved by the Commission de Surveillance du Secteur Financier (CSSF) and authorised to market their units or shares in the French Republic in accordance with the notification procedure under Article 93 of Directive 2009/65/EC. Investors should note that the prospectuses of certain Lyxor ETFs under Luxembourg law that have been notified in accordance with this procedure are only available on the website in English. A French translation of these prospectuses can be obtained upon request by sending a letter to Lyxor International Asset Management (“Lyxor”) – 17 Cours Valmy, 92987 Paris La Défense, France.

 

The information on this website is not intended for persons or entities that are resident, located or registered in jurisdictions that are not authorised to distribute Lyxor ETFs. As a result, the information on this website does not constitute an offer or solicitation to buy or sell units or shares in these ETFs by anyone in any jurisdiction:

 

(a)   in which such an offer or solicitation is unauthorised;

(b)   in which Lyxor is not qualified to make such an offer or solicitation; or 

(c)   in which it is unlawful to make such an offer or solicitation.

 

In particular, the Lyxor ETFs on this website are not and will not be registered under the United States Securities Act of 1933, as amended. As such, they may not be offered or sold within the United States of America, except in specific cases where transactions are exempt from registration under the Securities Act. The ETFs listed on this website may not be sold to US citizens or transferred to the United States by any other means, unless this transaction is not subject to any specific registration under US law. 

 

Any person from a jurisdiction to which the above-mentioned restrictions apply should inform themselves of and observe these restrictions.

 

This website is intended for commercial purposes and is not regulatory in nature. Although the information provided has been drawn up on the basis of sources considered to be reliable, there is no guarantee that it is accurate, complete or relevant. Some of the information on this website is provided on the basis of market data collected at a specific time and may therefore vary over time. Lyxor advises investors to read the risk factors section of the prospectus and the key investor information document carefully. These documents can be found on the website.

 

The net asset value (“NAV”) of Lyxor ETFs may at any time be subject to considerable price fluctuations, which in some cases may lead to the loss of all of the capital invested. Investors should note that some ETFs may be sensitive to fluctuations in the exchange rate between their reference currency and that of the underlying index, as well as of the components of the underlying index.

 

Before investing in a Lyxor ETF, you should carry out your own risk analysis of the product from a legal, tax and accounting perspective, rather than basing your decision solely on the information provided. If necessary, you should consult your own advisers or any other qualified professional. 

 

Subject to compliance with the legal obligations by which they are bound, Lyxor or any entity within the same group shall not be held liable for any financial or other consequences of an investment in the product. 

 

 

By clicking on institutional or individual above, I confirm that I have read and understood the information provided herein, and that I am resident or registered in Luxembourg.

 

By continuing to browse the site, you are agree on the use of cookies to track the number of visits.To know more about cookies policy:Click here

Latest from Lyxor

Latest from Lyxor

17 Feb. 2020 – Coronavirus still in focus

Coronavirus remains the main focus of news headlines over the past week, while dovish comments from the Federal Reserve gave a temporary boost to risk assets. Data releases over the week suggested that economic activity is resilient in the US but that it remains weak in the euro zone.

Next week, in the US the Federal Reserve will publish its minutes, in which markets will look for further details about the central bank’s inflation expectations. In Europe, preliminary PMI releases and the German ZEW survey may provide clues about the early impact of coronavirus on sentiment and about the outlook for global supply and demand chains. In Asia, the focus will be on China’s battle to contain the coronavirus and how the economy is holding up after the extended shutdowns in the country. Further policy measures aimed at supporting activity are likely over the coming weeks.

Source: Lyxor International Asset Management. Figures reported in local currency terms. Past performance is no guide to future returns. Data as at

Our key calls

Week commencing 12/02/2020

Favour growth stocks in the US

The Fed is keeping a close eye on the potential effects of coronavirus on supply chains and economic activity and is likely to maintain its dovish bias for now. US bond yields are likely to remain anchored at a low level for longer. This should further bolster growth stocks in the short term.


Buy European equities for the long term

While we expect a modest improvement in European activity in 2020, uncertainty about global trade persists. US-EU trade talks are proving challenging, and Europe is also exposed to the global supply chain risks linked to the coronavirus outbreak in China. In our view, the negative impacts of these forces on market performance should only be temporary, which is why we still like European equities over the long term.

Manage Chinese equities independently of a broad emerging equities portfolio

We believe an allocation to Chinese equities should be managed independently of a broader emerging equities portfolio. Adopting such an approach enables investors to take greater exposure to other markets with improving fundamentals and vary their allocation to China depending on the prevailing market conditions.

Things we are watching out for

The Main Event

comming soon

15
July

Coming soon...

Other major events

4 more things to put in the diary

19 Feb

Fed minutes, Huawei waivers, Democrat debate

22
Feb

Democrats primaries

12 Mar

ECB monetary policy meeting (with projections)

15 Mar

BoE Carney mandate ends. Bailey takes the lead.

Stress-test your decision

Use our simple tools to find out how your peers are investing, how markets are performing or to determine whether an active or passive strategy is most effective in your chosen area

Hot Topics

What your peers read, the products they looked at and the tools they used most last week

These are the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists as at 23 09 2019. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/ or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to   ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees. Click here for more.